Shi W, Zhang W, Zhang D, et al
PfGrx-dependent reduction kinetics for roGFP2 WT (S 2 ) To address the previously suggested alternative models for the glutaredoxin-dependent reduction of non-glutathione protein disulfides (Fig
StatPearls: StatPearls Publishing
Using prescription sequences spanning 2018 through 2025, we quantified switching frequency, described therapy-to-therapy transitions, and evaluated associations between current therapy, patient characteristics, and switching while explicitly accounting for switching opportunity and calendar time
Our experience shows that researchers who are meticulous about their cold chain protocols from the moment of delivery achieve far more consistent and trustworthy results
doi:10.1097/JCN.0000000000000469